Accuray ARAY
Accuray announces first phase of comprehensive strategic, operational, and organizational
- Form
- 8-K
- Filed
- Importance
- Routine
- Accession
- 0001193125-25-319896
- Signs a material agreement (1.01)
- Announces exit or restructuring costs (2.05)
- Sells unregistered shares (3.02)
- Makes a Regulation FD disclosure (7.01)
Not explained yet; the original is on EDGAR.
Similar companies
Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.
- Lucid Diagnostics LUCD public float $83M, Jun 30, 2025
- Fonar FONR
- Apyx Medical APYX public float $80M, Jun 30, 2025
- Microbot Medical MBOT public float $96M, Jun 30, 2025
- TELA Bio TELA public float $77M, Jun 30, 2025
